Skip to main content
Bio-Gate AG logo

Bio-Gate AG — Investor Relations & Filings

Ticker · BIG1 ISIN · DE000BGAG981 LEI · 391200G5LKTIOTZOXP90 F Manufacturing
Open in API
Filings indexed 242 across all filing types
Latest filing 2017-04-27 Earnings Release
Country DE Germany
Listing F BIG1

About Bio-Gate AG

https://www.bio-gate.de/en/

Bio-Gate AG is a provider of innovative technologies and customized solutions for health and hygiene, specializing in antimicrobial and antiviral strategies. The company enhances materials and products by incorporating its unique silver-based technologies, such as MicroSilver BG™. Key applications are concentrated in the medical technology sector, including the coating of medical implants and wound dressings to prevent infections. The company's technologies are also utilized in derma-cosmetics and veterinary care products. Furthermore, Bio-Gate provides solutions for industrial and consumer goods, imparting antimicrobial properties to items like paints, coatings, plastics, and textiles.

Recent filings

Filing Released Lang Actions
Bio-Gate AG verzeichnet 2016 Wachstumssprung und erzielt positives EBIT
Earnings Release Classification · 100% confidence The document is a news release dated April 27, 2017, titled "Bio-Gate AG verzeichnet 2016 Wachstumssprung und erzielt positives EBIT" (Bio-Gate AG records growth leap in 2016 and achieves positive EBIT). It details key financial figures for the 2016 fiscal year, including revenue growth, positive EBITDA, and EBIT, and provides a forecast for 2017. The structure and content strongly indicate an initial announcement of periodic financial results, focusing on key highlights rather than the comprehensive detail expected in a full Annual Report (10-K) or Interim Report (IR). This aligns perfectly with the definition of an Earnings Release (ER). The presence of the DGAP header confirms it is a formal corporate news announcement. FY 2016
2017-04-27 German
Jahresabschluss zum Geschäftsjahr vom 01.01.2015 bis zum 31.12.2015
Annual Report Classification · 100% confidence The document is a formal 'Jahresabschluss' (Annual Financial Statement) for Bio-Gate AG for the fiscal year 2015. It contains a balance sheet (Bilanz), profit and loss statement (Gewinn- und Verlustrechnung), and detailed notes (Anhang) as required by German commercial law (HGB). It provides comprehensive financial data and analysis for the full fiscal year, fitting the definition of an Annual Report (10-K) in the context of international financial reporting standards, despite being a standalone statutory filing. FY 2015
2017-01-05 German
Bio-Gate AG grundet Joint Venture und bestatigt Prognose fur 2016
Regulatory Filings Classification · 99% confidence The document is a news release dated December 14, 2016, originating from Bio-Gate AG, distributed via DGAP-News. The content announces the formation of a Joint Venture and confirms the financial forecast for 2016, stating that the revenue growth and positive operating result (EBITDA) are expected to be achieved. This structure—a brief announcement covering operational news (JV) and a confirmation of financial guidance—is characteristic of an Earnings Release (ER) or a general corporate update. Since it confirms the full-year forecast ('Prognose für 2016 wird vollumfänglich erreicht') rather than presenting detailed, period-specific financial statements (which would suggest IR or 10-K), it aligns best with an Earnings Release (ER) which typically provides key highlights and outlook confirmation. It is not a full transcript (CT), a formal annual report (10-K), or a standalone audit report (AR). It is a timely announcement of financial status confirmation.
2016-12-14 German
DGAP-DD: Bio-Gate AG deutsch
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains structured data detailing a transaction ('Zeichnung einer Kapitalerhöhung' - Subscription to a capital increase) by a person in a leadership role ('Volker Rofalski', 'Aufsichtsrat' - Supervisory Board member) related to the issuer (Bio-Gate AG). This directly corresponds to the definition of Director's Dealing reports.
2016-09-27 German
DGAP-DD: Bio-Gate AG deutsch
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains structured data detailing a transaction by a member of management ('Vorstand' - Executive Board Member Karl Richter) involving the company's shares ('Art: Aktie'). This directly corresponds to the definition of Director's Dealing (insider trades). Filing Category: DIRS (Director's Dealing).
2016-09-27 German
DGAP-DD: Bio-Gate AG deutsch
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains the German equivalent header 'DGAP-DD: Bio-Gate AG deutsch' and 'Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen' (Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them). It details a transaction (Zeichnung einer Kapitalerhöhung - Subscription to a capital increase) by an individual related to the board ('Aufsichtsrat'). This directly corresponds to the definition of Director's Dealing.
2016-09-27 German

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.